IL23A and experimental autoimmune encephalomyelitis: While IL-12/IL-23 dysregulation has long been considered to drive the pathogeneses of several autoimmune diseases such as experimental autoimmune encephalomyelitis and arthritis [47, 49], recent evidence shows that dysregulated IL-12/IL-23 signaling can also contribute to AD.